CEREVEL THERAPEUTICS HOLDINGS INCCEREVEL THERAPEUTICS HOLDINGS INCCEREVEL THERAPEUTICS HOLDINGS INC

CEREVEL THERAPEUTICS HOLDINGS INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
−2.53EUR
‪−392.16 M‬EUR
Beta (1Y)
0.21
Employees (FY)
334.00
Revenue / Employee (1Y)
0.00EUR
Net income / Employee (1Y)
‪−1.30 M‬EUR

About CEREVEL THERAPEUTICS HOLDINGS INC


CEO
Ronald C. Renaud
Headquarters
Cambridge
Founded
2018
FIGI
BBG01BV0JYC1
Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. Its product candidates include CVL-231, Darigabat, Tavapadon, CVL-871, and CVL-936. The company was founded in 2018 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Frequently Asked Questions


The current price of 673 is 41.60 EUR — it has increased by 0.97% in the past 24 hours. Watch CEREVEL THERAPEUTICS HOLDINGS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange CEREVEL THERAPEUTICS HOLDINGS INC stocks are traded under the ticker 673.
673 reached its all-time high on Jul 31, 2024 with the price of 41.60 EUR, and its all-time low was 18.80 EUR and was reached on Aug 7, 2023. View more price dynamics on 673 chart.
See other stocks reaching their highest and lowest prices.
673 stock is 1.96% volatile and has beta coefficient of 0.21. Track CEREVEL THERAPEUTICS HOLDINGS INC stock price on the chart and check out the list of the most volatile stocks — is CEREVEL THERAPEUTICS HOLDINGS INC there?
Yes, you can track CEREVEL THERAPEUTICS HOLDINGS INC financials in yearly and quarterly reports right on TradingView.
CEREVEL THERAPEUTICS HOLDINGS INC is going to release the next earnings report on Nov 6, 2024. Keep track of upcoming events with our Earnings Calendar.
673 net income for the last quarter is ‪−122.25 M‬ EUR, while the quarter before that showed ‪−120.19 M‬ EUR of net income which accounts for −1.72% change. Track more CEREVEL THERAPEUTICS HOLDINGS INC financial stats to get the full picture.
No, 673 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 30, 2024, the company has 334.00 employees. See our rating of the largest employees — is CEREVEL THERAPEUTICS HOLDINGS INC on this list?
Like other stocks, 673 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CEREVEL THERAPEUTICS HOLDINGS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CEREVEL THERAPEUTICS HOLDINGS INC technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CEREVEL THERAPEUTICS HOLDINGS INC stock shows the strong buy signal. See more of CEREVEL THERAPEUTICS HOLDINGS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.